Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NovaBridge Biosciences
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
March 16, 2026
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
March 9, 2026
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
March 3, 2026
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
February 17, 2026
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
January 20, 2026
←
Previous Page
1
2